Literature DB >> 10073737

Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics.

J X Mazoit1, K Samii.   

Abstract

AIMS: Propofol is a widely used i.v. anaesthetic agent. However, its binding properties to blood components have not been fully studied.
METHODS: We studied the binding of propofol to erythrocytes, to human serum and to isolated serum proteins. Because propofol bound to ultrafiltration and equilibrium dialysis membranes, we used a co-binding technique with dextran coated charcoal and with erythrocytes.
RESULTS: Propofol free fraction in blood was 1.2-1.7% at total concentrations ranging from 2.80 to 179 microM (0.5 to 32 microg ml(-1)). Fifty percent was bound to erythrocytes and 48% to serum proteins, almost exclusively to human serum albumin. In the clinical range of concentrations (0.5-16 microg ml(-1)) 40% of the molecules bound to erythrocytes are on the red blood cells membranes. No binding to lipoproteins occurred and binding to alpha1-acid glycoprotein was less than 1.5%
CONCLUSIONS: We conclude that hypoalbuminaemia may increase propofol free fraction particularly during prolonged administration. Since propofol is non-restrictively cleared, no change in clearance is expected to occur, and the increase in free fraction will not be compensated by a parallel increase in clearance. It is also noted that many in vitro studies used concentrations 50 to 500 times the concentration expected to be encountered in the immediate cellular environment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073737      PMCID: PMC2014200          DOI: 10.1046/j.1365-2125.1999.00860.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  27 in total

1.  Pharmacokinetics of propofol during and after long-term continuous infusion for maintenance of sedation in ICU patients.

Authors:  G R Bailie; I D Cockshott; E J Douglas; B J Bowles
Journal:  Br J Anaesth       Date:  1992-05       Impact factor: 9.166

2.  Disposition of propofol at caesarean section and in the postpartum period.

Authors:  T Gin; G Yau; W Jong; P Tan; R K Leung; K Chan
Journal:  Br J Anaesth       Date:  1991-07       Impact factor: 9.166

3.  Pharmacodynamics of propofol and free drug concentrations.

Authors:  T Gin
Journal:  Anesthesiology       Date:  1993-03       Impact factor: 7.892

Review 4.  Plasma protein binding displacement interactions--why are they still regarded as clinically important?

Authors:  P E Rolan
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

5.  Pharmacodynamics of propofol in female patients.

Authors:  J Vuyk; F H Engbers; H J Lemmens; A G Burm; A A Vletter; M P Gladines; J G Bovill
Journal:  Anesthesiology       Date:  1992-07       Impact factor: 7.892

6.  Pharmacokinetics and protein binding of propofol in patients with cirrhosis.

Authors:  F Servin; J M Desmonts; J P Haberer; I D Cockshott; G F Plummer; R Farinotti
Journal:  Anesthesiology       Date:  1988-12       Impact factor: 7.892

7.  Propofol activates GABAA receptor-chloride ionophore complex in dissociated hippocampal pyramidal neurons of the rat.

Authors:  M Hara; Y Kai; Y Ikemoto
Journal:  Anesthesiology       Date:  1993-10       Impact factor: 7.892

8.  Increased erythrocyte and protein binding of codeine in patients with sickle cell disease.

Authors:  S S Mohammed; M M Christopher; P Mehta; A Kedar; S Gross; H Derendorf
Journal:  J Pharm Sci       Date:  1993-11       Impact factor: 3.534

9.  Effects of propofol and thiopental on coronary blood flow and myocardial performance in an isolated rabbit heart.

Authors:  S Mouren; J F Baron; C Albo; B Szekely; M Arthaud; P Viars
Journal:  Anesthesiology       Date:  1994-03       Impact factor: 7.892

10.  Effects of propofol and thiopental in isolated rat aorta and pulmonary artery.

Authors:  W K Park; C Lynch; R A Johns
Journal:  Anesthesiology       Date:  1992-11       Impact factor: 7.892

View more
  31 in total

1.  Binding of propofol to blood components.

Authors:  E Suarez; R Calvo; M K Zamacona; J Lukas
Journal:  Br J Clin Pharmacol       Date:  2000-04       Impact factor: 4.335

2.  Rapid analysis of the interactions between drugs and human serum albumin (HSA) using high-performance affinity chromatography (HPAC).

Authors:  Hee Seung Kim; Irving W Wainer
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-05-24       Impact factor: 3.205

3.  In vitro changes in the proportion of protein-unbound-free propofol induced by valproate.

Authors:  Minako Ishii-Maruhama; Hitoshi Higuchi; Mai Nakanou; Yuka Honda-Wakasugi; Akiko Yabuki-Kawase; Shigeru Maeda; Takuya Miyawaki
Journal:  J Anesth       Date:  2018-07-30       Impact factor: 2.078

Review 4.  Pharmacokinetic/pharmacodynamic modeling of anesthetics in children: therapeutic implications.

Authors:  Jean-Xavier Mazoit
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

5.  Cerebrospinal fluid and plasma propofol concentration during total intravenous anaesthesia of patients undergoing elective intracranial tumor removal.

Authors:  Wei Luo; Yu-Hong Li; Jian-Jun Yang; Jie Tian; Jian-Guo Xu
Journal:  J Zhejiang Univ Sci B       Date:  2005-09       Impact factor: 3.066

6.  Potential network mechanisms mediating electroencephalographic beta rhythm changes during propofol-induced paradoxical excitation.

Authors:  Michelle M McCarthy; Emery N Brown; Nancy Kopell
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

7.  GABAergic mechanism of propofol toxicity in immature neurons.

Authors:  Sibel Kahraman; Susan L Zup; Margaret M McCarthy; Gary Fiskum
Journal:  J Neurosurg Anesthesiol       Date:  2008-10       Impact factor: 3.956

8.  Propofol at clinically relevant concentrations increases neuronal differentiation but is not toxic to hippocampal neural precursor cells in vitro.

Authors:  Jeffrey W Sall; Greg Stratmann; Jason Leong; Elliott Woodward; Philip E Bickler
Journal:  Anesthesiology       Date:  2012-11       Impact factor: 7.892

9.  Disposition and pharmacodynamics of propofol during isovolaemic haemorrhage followed by crystalloid resuscitation in humans.

Authors:  Eri Takizawa; Daisuke Takizawa; Haruhiko Hiraoka; Shigeru Saito; Fumio Goto
Journal:  Br J Clin Pharmacol       Date:  2006-03       Impact factor: 4.335

10.  Effect of propofol on cardiac function and gene expression after ischemic-reperfusion in isolated rat heart.

Authors:  Youn Jin Kim; Hae Ja Lim; Sung Uk Choi
Journal:  Korean J Anesthesiol       Date:  2010-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.